Management of Uremic Pruritus in Non-Dialysis Hospice Patients
For non-dialysis hospice patients with uremic pruritus, start with emollients for xerosis, then use oral gabapentin (with careful dose reduction for renal function) as the primary pharmacologic agent, and consider sedating antihistamines specifically in this palliative context where the dementia risk is acceptable given limited life expectancy.
Stepwise Treatment Approach
First-Line: Emollients
Begin with simple emollients to address xerosis (dry skin), which is nearly universal in kidney disease and lowers the threshold for itch 1. This foundational step should be maintained throughout treatment.
Second-Line: Gabapentin
Gabapentin is the most evidence-based systemic treatment for uremic pruritus 1, 2. In non-dialysis patients with reduced kidney function, use significantly lower doses than standard:
- Start with 100 mg daily or every other day
- Titrate slowly based on response and tolerability
- Monitor for drowsiness, which is common but may be acceptable in hospice care
- The evidence shows strong antipruritic effects with visual analogue scale reductions exceeding 50% 1, 3
Third-Line: Topical Options
If gabapentin is insufficient or not tolerated, consider:
Palliative-Specific Consideration: Sedating Antihistamines
In the hospice setting specifically, sedating antihistamines become an acceptable option 1. While guidelines strongly recommend avoiding long-term sedative antihistamines due to dementia risk (Strength B recommendation), they explicitly state these should be avoided "except in palliative care" 1. Options include:
- Doxepin 10 mg twice daily (showed 58% complete resolution in dialysis patients) 1
- The sedation effect may actually be beneficial for sleep disturbances common in hospice patients
Alternative Systemic Agents
Based on palliative care evidence, consider 3:
- Paroxetine - showed strong effect for pruritus of diverse origins in palliative patients
- Mirtazapine - effective for various pruritus types including uremic
Important Caveats
Avoid cetirizine - it is specifically ineffective in uremic pruritus 1
Dose adjustments are critical - Non-dialysis patients with kidney disease require substantially lower doses than standard populations. Gabapentin doses in CKD are typically 100-300 mg compared to standard doses, and must be further reduced based on GFR 1.
No single treatment is universally effective - The guidelines explicitly state "no single topical/systemic treatment strategy is effective" for uremic pruritus 1. This necessitates a trial-and-error approach with sequential therapies.
Quality of life is paramount - In hospice care, prioritize symptom relief over concerns about long-term side effects like dementia risk from antihistamines, as the guidelines specifically carve out this exception 1.
Complementary Approaches
Consider non-pharmacologic options 1:
- Auricular acupressure
- Aromatherapy
- These have low risk and may provide additional benefit
The evidence base for uremic pruritus treatment remains limited, with most recommendations at Strength D (expert opinion) level 1. However, the combination of emollients, carefully dosed gabapentin, and judicious use of sedating antihistamines in the hospice context provides the most rational evidence-based approach for this challenging symptom.